CRNO B — Cereno Scientific AB Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro CapNeutral
- SEK63.39m
- SEK19.17m
Annual cashflow statement for Cereno Scientific AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11.8 | -15.3 | -16 | -16.3 | -27.7 |
| Depreciation | |||||
| Non-Cash Items | 2.15 | 1.97 | 0.974 | 0.228 | 0.156 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.93 | -8.11 | -1.12 | 2.88 | 8.87 |
| Change in Accounts Receivable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -8.76 | -21.4 | -16.1 | -13.1 | -18.6 |
| Capital Expenditures | -7.74 | -12 | -8.23 | -44.8 | -57.5 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -0.065 | -0.008 | — | — |
| Purchase of Investments | |||||
| Cash from Investing Activities | -7.74 | -12 | -8.24 | -44.8 | -57.5 |
| Financing Cash Flow Items | -3.4 | -12.6 | -4.93 | -4.24 | -3.12 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 19.1 | 48.3 | 64.3 | 81.6 | 53.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.6 | 14.9 | 39.9 | 23.6 | -22.6 |